Premium Information is available for this item - Upgrade for $1 a day
6505-00-771-9234
Usp Lidocaine Hydrochloride Injection
6505007719234 007719234 NDC00185-0221-26 201-50 NDC00467-3201-25 452390 NDC00641-2390-45
January 2023
6
Marketplace 6505-00-771-9234
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-771-9234 5+ Documents (More...)
Usp Lidocaine Hydrochloride Injection 9234Usp Lidocaine Hydrochloride Injection6505007719234 007719234
NDC00185-0221-26 201-50 NDC00467-3201-25 60567 - Lyphomed Inc Div Of Fujisawa Usa Inc (Obsolete) Primary
Hydrochloride Injection 9237 Usp Lidocaine Hydrochloride Injection 182-8651 6505-33-005-1467 6505-00-771-9234
6505/br 6505-19-000-5067 Lidocaine Hydrochloride Injection 190005067 182-8651 6505-33-005-1467 6505-00-771-9234
Usp Lidocaine Hydrochloride Injection 6505-01-182-8651 6505-33-005-1467 6505-00-771-9234 https/
003-2237 6505-17-105-7121 6505-01-447-8094 6505-01-305-8175 6505-01-182-8651 6505-33-005-1467 6505-00-771-9234
Usp Lidocaine Hydrochloride Injection 6505-01-182-8651 6505-33-005-1467 6505-00-771-9234 https/
003-2237 6505-17-105-7121 6505-01-447-8094 6505-01-305-8175 6505-01-182-8651 6505-33-005-1467 6505-00-771-9234
Restrictions 6505-00-771-9234
6505-00-771-9234 is a Usp Lidocaine Hydrochloride Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-00-771-9234
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-00-771-9234
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-771-9234
- Part Number
- Manufacturer
- Status
- NDC00185-0221-26
- Manufacturer
- 04532 - Vitarine Co Inc The (Obsolete)
- Primary Buy
- Primary Buy
- 201-50
- 60567 - Lyphomed Inc Div Of Fujisawa Usa Inc (Obsolete)
- Primary Buy
- Primary Buy
- NDC00467-3201-25
- 60567 - Lyphomed Inc Div Of Fujisawa Usa Inc (Obsolete)
- Primary Buy
- Primary Buy
- 452390
- 51968 - Elkins-Sinn Inc (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
- NDC00641-2390-45
- 51968 - Elkins-Sinn Inc (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-00-771-9234
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 1.000 Percentage, W/V Lidocaine Hydrochloride Active Ingredient
- Primary Container Type [CQCT]
- Vial
- Primary Container Content Quantity [CRLK]
- 50.000 Milliliters
- Special Features [FEAT]
- Without Epinephrine; Multiple Dose Vial
Management Data 6505-00-771-9234
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Apr 1994
- Veterans Administration (VA)
- VI
- Subscribe
- 1
- VI
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 50 Ml
- 00000000050ML
- K
NATO Stock Numbers Related to 6505-00-771-9234
Freight Information 6505-00-771-9234
6505-00-771-9234 has freight characteristics.. 6505-00-771-9234 has a variance between NMFC and UFC when transported by rail and the description should be consulted.